Management of overt upper gastrointestinal bleeding in a low resource setting: a real world report from Nigeria

BMC Gastroenterology

Anthony O Arigbabu¹  Augustine E Agbakwuru¹  Olusegun Adekanle²  Adewale O Adisa¹  Adeniyi S Aderibigbe¹  Olusegun I Alatise¹ 

[1] Department of Surgery, College of Health Sciences, Obafemi Awolowo University Teaching Hospital Complex, PMB 5538, Ile-Ife, Osun State, Nigeria;Department of Medicine, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria

关键词: Nigeria;    Outcome;    Surgery;    Therapeutic;    Upper gastrointestinal bleeding;   

Others  :  1121742
DOI  :  10.1186/s12876-014-0210-1

 received in 2014-07-28, accepted in 2014-12-02,  发布年份 2014

【 摘 要 】

Background

Upper gastrointestinal bleeding (UGIB) remains a common medical problem worldwide that has significant associated morbidity, mortality, and health care resource use. This study outlines the aetiology, clinical presentation, and treatment outcomes of patients with UGIB in a Nigerian low resource health facility.

Methods

This was a descriptive study of consecutive patients who underwent upper gastrointestinal (GI) endoscopy for upper GI bleeding in the endoscopy unit of the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Osun State, Nigeria from January 2007 to December 2013.

Results

During the study period, 287 (12.4%) of 2,320 patients who underwent upper GI endoscopies had UGIB. Of these, 206 (72.0%) patients were males and their ages ranged from 3 to 100 years with a median age of 49 years. The main clinical presentation included passage of melaena stool in 268 (93.4%) of individuals, 173 (60.3%) had haematemesis, 110 (38.3%) had haematochezia, and 161 (56.1%) were dizzy at presentation. Observed in 88 (30.6%) of UGIB patients, duodenal ulcer was the most common cause, followed by varices [52 (18.1%)] and gastritis [51 (17.1%)]. For variceal bleeding, 15 (28.8%) and 21 (40.4%) of patients had injection sclerotherapy and variceal band ligation, respectively. The overall rebleeding rate for endoscopic therapy for varices was 16.7%. For patients with ulcers, only 42 of 55 who had Forrest grade Ia to IIb ulcers were offered endoscopic therapy. Endoscopic therapy was áin 90.5% of the cases. No rebleeding followed endoscopic therapy for the ulcers. The obtained Rockall scores ranged from 2 to 10 and the median was 5.0. Of all patients, 92.7% had medium or high risk scores. An increase in Rockall score was significantly associated with length of hospital stay and mortality (p < 0.001). The overall mortality rate was 5.9% (17 patients).

Conclusion

Endoscopic therapy for UGIB in a resource-poor setting such as Nigeria is feasible, significantly reduces morbidity and mortality, and is cost effective. Efforts should be made to improve the accessibility of these therapeutic procedure for patients with UGIB in Nigeria.

【 授权许可】

   
2014 Alatise et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Majno G: The Healing Hand, man and Wound in the Ancient World. Harvard University Press, Cambridge; 1975.
• [2]Esrailian E, Ian M, Gralnek IM: Nonvariceal upper gastrointestinal bleeding: epidemiology and diagnosis. Gastroenterol Clin N Am 2005, 34:589-605.
• [3]Bessa X, O’Callaghan E, Balleste B, Nieto M, Seoane A, Panades A, Vazquez DJ, Andreu M, Bory F: Applicability of the Rockall score in patients undergoing endoscopic therapy for upper gastrointestinal bleeding. Dig Liver Dis 2006, 38:12-17.
• [4]Lu Y, Loffroy R, Lau JY, Barkun A: Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Br J Surg 2014, 101(1):e34-e50.
• [5]Jensen DM, Machicado GA: Endoscopic hemostasis of ulcer hemorrhage with injection, thermal, and combination methods. Tech Gastrointest Endosc 2005, 7:124-131.
• [6]Meaden C, Makin AJ: Diagnosis and treatment of patients with gastrointestinal bleeding. Curr Anaesthesia Crit Care 2004, 15:123-132.
• [7]Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW: Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010, 105(1):84-89.
• [8]Peng Y, Chen S, Tung C, Chou W, Hu WMD, Yang S: Factors associated with failure of initial endoscopic hemoclip hemostasis for upper gastrointestinal bleeding. J Clin Gastroenterol 2006, 40:25-28.
• [9]Spiegel B, Vakil N, Ofman J: Endoscopy for acute nonvariceal upper gastrointestinal tract hemorrhage: is sooner better? A systematic review. Arch Intern Med 2001, 161:1393-1404.
• [10]Lee JG, Turnipseed S, Romano PS, Lee JG, Turnipseed S, Romano PS, Vigil H, Azari R, Melnikoff N, Hsu R, Kirk D, Sokolove P, Leung JW: Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc 1999, 50:755-761.
• [11]Hay JA, Maldonado L, Weingarten SR, Hay JA, Maldonado L, Weingarten SR, Ellrodt AG: Prospective evaluation of a clinical guideline recommending hospital length of stay in upper gastrointestinal tract hemorrhage. J Am Med Assoc 1997, 278:2151-2156.
• [12]Ladep NG, Sule J, Umar SM, Obienu O, Anyanechi C, Okeke EN: Oesophageal variceal band ligation using a saeed six-shooter multiband ligator, experience at Jos University Teaching Hospital, Nigeria: case report. Niger J Med 2008, 17:110-111.
• [13]Arigbabu AO, Akinola DO: Endoscopic sclerotherapy for oesophageal varices. Current status in Nigeria. Trop Doct 1987, 17(3):111-113.
• [14]Forrest JA, Finlayson ND, Shearman DJ: Endoscopy in gastrointestinal bleeding. Lancet 1974, 2:394-397.
• [15]Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M: Right liver lobe/albumin ratio: contribution to noninvasive assessment of portal hypertension. World J Gastroenterol 2007, 13(40):5331-5335.
• [16]Rockall TA, Logan RFA, Devlin HB, Northfield TC: Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. Lancet 1996, 347:1138-1140.
• [17]Cryer BL, Wilcox CM, Henk HJ, Zlateva G, Chen L, Zarotsky V: The economics of upper gastrointestinal bleeding in a US managed-care setting: a retrospective, claims-based analysis. J Med Econ 2010, 13(1):70-77.
• [18]Agbakwuru EA, Fatusi AO, Ndububa DA, Alatise OI, Arigbabu OA, Akinola DO: Pattern and validity of clinical diagnosis of upper gastrointestinal diseases in south-west Nigeria. Afr Health Sci 2006, 6(2):98-103.
• [19]Malu AO, Wali SS, Kazmi R, Macauley D, Fakunle YM: Upper gastrointestinal endoscopy in Zaria, northern Nigeria. West Afr J Med 1990, 9(4):279-284.
• [20]Olokoba AB, Bojuwoye BJ: Indications for oesophagogastroduodenoscopy in Ilorin, Nigeria–a 30 month review. Niger J Clin Pract 2010, 13(3):260-263.
• [21]Arora NK, Ganguly S, Mathur P, Ahuja A, Patwari A: Upper gastrointestinal bleeding: etiology and management. Indian J Pediatr 2002, 69(2):155-168.
• [22]Jaka H, Koy M, Liwa A, Kabangila R, Mirambo M, Scheppach W, Mkongo E, McHembe MD, Chalya PL: A fibreoptic endoscopic study of upper gastrointestinal bleeding at Bugando Medical Centre in northwestern Tanzania: a retrospective review of 240 cases. BMC Res Notes 2012, 3(5):200. BioMed Central Full Text
• [23]Zaltman C, Souza HS, Castro ME, Sobral MF, Dias PC, Lemos V: Upper gastrointestinal bleeding in a Brazilian hospital: a retrospective study of endoscopic records. Arq Gastroenterol 2002, 39:74-80.
• [24]Suba M, Mekonnen SA, Mtabho CM, Kibiki GS: The aetiology, management and clinical outcome of upper gastrointestinal bleeding among patients admitted at the Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Tanzania J Health Res 2010, 12(4):286-289.
• [25]Mustapha S, Ajayi N, Shehu A: Aetiology of upper gastrointestinal bleeding in north-eastern nigeria: a retrospective endoscopic study. The Internet Journal of Third World Medicine 2009, 8:2.
• [26]Kim JJ, Sheibani S, Park S, Buxbaum J, Laine L: Causes of bleeding and outcomes in patients hospitalized with upper gastrointestinal bleeding. J Clin Gastroenterol 2014, 48(2):113-118.
• [27]Laine L, Yang H, Chang SC, Laine L, Yang H, Chang SC, Datto C: Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol 2012, 107:1190-1195.
• [28]Loperfido S, Baldo V, Piovesana E, Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, Caroli A, Dal Bò N, Monica F, Fabris L, Salvat HH, Bassi N, Okolicsanyi L: Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009, 70:212-224.
• [29]van Leerdam ME: Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 2008, 22(2):209-224.
• [30]Hearnshaw SA, Logan RF, Lowe D, Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR: Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011, 60:1327-1335.
• [31]Alema ON, Martin DO, Okello TR: Endoscopic findings in upper gastrointestinal bleeding patients at Lacor hospital, northern Uganda. Afr Health Sci 2012, 4:518-521.
• [32]Gado AS, Ebeid BA, Abdelmohsen AM, Axon AT: Clinical outcome of acute upper gastrointestinal hemorrhage among patients admitted to a government hospital in Egypt. Saudi J Gastroenterol 2012, 18(1):34-39.
• [33]Elwakil R, Reda MA, Abdelhakam SM, Ghoraba DM, Ibrahim WA: Causes and outcome of upper gastrointestinal bleeding in Emergency Endoscopy Unit of Ain Shams University Hospital. J Egypt Soc Parasitol 2011, 41(2):455-467.
• [34]Ajayi AO, Adegun PT, Ajayi EA, Solomon OA, Adeoti AO, Akolawole MA: Aetiology and management outcome of upper gastrointestinal bleeding in adult patients presenting at ekiti state university teaching hospital, Ado-Ekiti, Nigeria. Greener J Med Sci 2013, 3(3):093-097.
• [35]Lee I, Cryer B: Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding. Gastrointest Endoscopy Clin N Am 2011, 21:597-612.
• [36]Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, Rodrigo L, Balanzo J, Bajador E, Almela P, Navarro JM, Carballo F, Castro M, Quintero E: Investigators of the Asociación Española de Gastroenterología (AEG): Investigators of the Asociacio’n Espanola de Gastroenterologıca (AEG). A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug use. Am J Gastroenterol 2005, 100(8):1685-1693.
• [37]Hermansson M, Ekedahl A, Ranstam J, Hermansson M, Ekedahl A, Ranstam J, Zilling T: Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974–2001. BMC Gastroenterol 2009, 9:25. BioMed Central Full Text
• [38]Sung JJ, Kuipers EJ, El-Serag HB: Systematic review: the global incidence and prevalence of peptic ulcer disease [review]. Aliment Pharmacol Ther 2009, 29(9):938-946.
• [39]De Berardis G, Lucisano G, D’Ettorre A, Pellegrini F, Lepore V, Tognoni G, Nicolucci A: Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 2012, 307(21):2286-2294.
• [40]Kohn A, Ancona C, Belleudi V, Davoli M, Giglio L, Fusco D, Andreoli A, Perucci C, Prantera C: SEID Appropriateness Working Group. The impact of endoscopy and specialist care on 30-day mortality among patients with acute non-variceal upper gastrointestinal hemorrhage: an Italian population-based study. Dig Liver Dis 2010, 42(9):629-634.
• [41]Senbanjo IO, Oshikoya KA, Njokanma OF: Helicobacter pylori associated with breastfeeding, nutritional status and recurrent abdominal pain in healthy Nigerian children. J Infect Dev Ctries 2014, 8(4):448-453.
• [42]Kawamura T, Yasuda K, Morikawa S, Itonaga M, Nakajima M: Current status of endoscopic management for nonvariceal upper gastrointestinal bleeding. Dig Endosc 2010, 22:S26-S30.
• [43]Vlavianos P, Westaby D: Management of acute variceal haemorrhage. Eur J Gastroenterol Hepatol 2001, 13(4):335-342.
• [44]Theocharis GJ, Thomopoulos KC, Sakellaropoulos G, Katsakoulis E, Nikolopoulou V: Changing trends in the epidemiology and clinical outcome of acute upper gastrointestinal bleeding in a defined geographical area in Greece. J Clin Gastroenterol 2008, 42(2):128-133.
• [45]Bae S, Kim N, Kang JM, Kim DS, Kim KM, Cho YK, Kim JH, Jung SW, Shim KN: Incidence and 30-day mortality of peptic ulcer bleeding in Korea. Eur J Gastroenterol Hepatol 2012, 24(6):675-682.